Abstract:Background Alzheimer's disease (AD) is characterized by progressive deterioration of cognitive functions. Some individuals with subjective cognitive decline (SCD) are in the early phase of the disease and subsequently progress through the AD continuum. Although neuroimaging biomarkers could be used for the accurate and early diagnosis of preclinical AD, the findings in SCD samples have been heterogeneous. This study established the morphological differences in brain magnetic resonance imaging (MRI) findings between individuals with SCD and those without cognitive impairment based on a clinical sample of patients defined according to SCD-Initiative recommendations. Moreover, we investigated baseline structural changes in the brains of participants who remained stable or progressed to mild cognitive impairment or dementia. Methods This study included 309 participants with SCD and 43 healthy controls (HCs) with high-quality brain MRI at baseline. Among the 99 subjects in the SCD group who were followed clinically, 32 progressed (SCDp) and 67 remained stable (SCDnp). A voxel-wise statistical comparison of gray and white matter (WM) volume was performed between the HC and SCD groups and between the HC, SCDp, and SCDnp groups. XTRACT ATLAS was used to define the anatomical location of WM tract damage. Region-of-interest (ROI) analyses were performed to determine brain volumetric differences. White matter lesion (WML) burden was established in each group. Results Voxel-based morphometry (VBM) analysis revealed that the SCD group exhibited gray matter atrophy in the middle frontal gyri, superior orbital gyri, superior frontal gyri, right rectal gyrus, whole occipital lobule, and both thalami and precunei. Meanwhile, ROI analysis revealed decreased volume in the left rectal gyrus, bilateral medial orbital gyri, middle frontal gyri, superior frontal gyri, calcarine fissure, and left thalamus. The SCDp group exhibited greater hippocampal atrophy ( p < 0.001) than the SCDnp and HC groups on ROI analyses. On VBM analysis, however, the SCDp group exhibited increased hippocampal atrophy only when compared to the SCDnp group ( p < 0.001). The SCD group demonstrated lower WM volume in the uncinate fasciculus, cingulum, inferior fronto-occipital fasciculus, anterior thalamic radiation, and callosum forceps than the HC group. However, no significant differences in WML number ( p = 0.345) or volume ( p = 0.156) were observed between the SCD and HC groups. Conclusions The SCD group showed brain atrophy mainly in the frontal and occipital lobes. However, only the SCDp group demonstrated atrophy in the medial temporal lobe at baseline. Structural damage in the brain regions was anatomically connected, which may contribute to early memory decline.

A-06 MRI and Neuropsychological Change During Conversion from Normal/MCI to Alzheimer’s Disease

Memory Tests Predict the Change of Hippocampus Topography in Mild Cognitive Impairment Patients

P4‐172: Disruption of Intrinsic Functional Connectivity Within the Left Temporal Lobe is Linked to Cognition and Increased Total Tau Level in CSF in MCI Patients Who Will Progress to Alzheimer's Disease

Longitudinal Structural MRI Study in Process of Mild Cognitive Impairment Converting to AD Dementia

Progressive Brain Atrophy in Parkinson's Disease Patients Who Convert to Mild Cognitive Impairment.

Alterations in regional brain volume and individual MRI-guided perfusion in normal control, stable mild cognitive impairment, and MCI-AD converter.

Whole Brain Structural Changes Predict the Mild Cognitive Imparirment to Alzheimer's Disease Conversion: Evidence from the Alzheimer's Disease Neuroimaging Initiative

[O1–12–02]: PROGRESSION FROM PRECLINICAL AD TO MCI OVER A DECADE: COGNITIVE AND BRAIN IMAGING TRAJECTORIES

MRI Characterizes the Progressive Course of AD and Predicts Conversion to Alzheimer’s Dementia 24 Months Before Probable Diagnosis

Relationship Between Longitudinal, Structural Magnetic Resonance Imaging and [18f]fluorodeoxyglucose Positron Emission Tomography Data From The Alzheimer'S Disease Neuroimaging Initiative Study

C-27 Neuropsychological Differences in 10 Year Long-Term Stable Mild Cognitive Impairment and Converting Mild Cognitive Impairment

P4‐053: Relationship Between Longitudinal, Structural Magnetic Resonance Imaging and [18f]fluorodeoxyglucose Positron Emission Tomography Data from the Alzheimer'S Disease Neuroimaging Initiative Study

Longitudinal Changes in Surface Based Brain Morphometry Measures in Amnestic Mild Cognitive Impairment and Alzheimer's Disease

Resting-state fMRI markers of conversion to dementia in amnestic MCI: a pilot study

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

Combined cognitive assessment and automated MRI volumetry improves the diagnostic accuracy of detecting MCI due to Alzheimer's disease

Volumetric MRI and cognitive measures in Alzheimer disease

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample

IC-03-06: Six Month MRI Gray Matter Declines in Alzheimer's Dementia Evaluated by Voxel-Based Morphometry with Multivariate Network Analysis: Preliminary Findings from the ADNI Study

Analysis of Regional MRI Volumes and Thicknesses As Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease